SlideShare a Scribd company logo
CHEMOTHERAPY AND
ANTIBIOTICS
ANJU RANA
HISTORY
The term was used in the early 1900s by Paul Ehrlich for use
of chemicals to treat any disease (chemo+therapy), such as
the use of antibiotics (antibacterial chemotherapy).
First modern chemotherapeutic agent was arsphenamine,
an arsenic compound discovered in 1907 and used to
treat syphilis and was later followed by sulfonamides (sulfa
drugs) and penicillin. Nowadays the term ‘any treatment of
disease with drugs’ is expressed by a word
pharmacotherapy.
Chemotherapy is the use of chemical substances having property to
inhibit the growth of microorganism in treatment of diseases.
The chemical compounds that are used to kill or inhibit the growth of
microorganisms already established in the tissues of the body are known
as chemotherapeutic agents.
It may be given to prolong life or to reduce symptoms of a disease. The
first use of drugs to treat cancer was reported in the early 20th century,
although it was not originally intended for that purpose.
Goodman & Gilman used mustard gas as therapy
Mustard gas was used as a chemical warfare agent
during World War I and was discovered to be a potent
suppressor of hematopoiesis (blood production). The
accidental discovery that the mustard gas led to slow
progression of cancer cells in body encouraged Goodman
and Gilman to use it in patients with Hodgkin’s disease in
1943. From here chemotherapy began.
The chemotherapeutic agents are non-specific in action and are
cytotoxic.
One of the side effects of chemotherapy is damage to the normal cells
that divide rapidly and are sensitive to the anti-mitotic drugs like cells
in the bone marrow, digestive tract and hair follicles. This induces
decreased production of blood cells, inflammation of the lining of the
digestive tract and hair loss.
Chemotherapy damage or stress cells, which may lead to cell death if
apoptosis is initiated.
Commonly used chemotherapeutic drugs
Alkylating agents: These are one of the earliest and
commonly used drugs. They damage DNA and stops
cancer cells to replicate.
Fig. Antimetabolites inhibit the DNA synthesis
Anthracyclines: These are drugs used for treatment of cancer and thy act
by interfering with enzymes that are necessary for replication of DNA but
are not cell cycle specific, e.g. doxorubicin, mitimycin-C and bleomycin.
These are derived from Streptomyces percetus.
Plant alkaloids: These are derived from plants and are found to inhibit
cell division or interfere with necessary enzymes needed for cell division.
They can affect at any phase of cell division. They produce toxic effects
like haematopoesis or neurological toxicities. Examples of plant
alkaloides are: vinca alkaloid, vincristine, paclitaxel and docetaxel.
Antibiotics
Antibiotics were known by their activities long before they were given this
specific name that means ‘against life’.
Many years ago the Chinese used moldy curd to treat boils and controlled foot
infections by wearing sandals with layer of mold.
Pasteur and Joubert realised that growth of anthrax bacillus was inhibited by
certain other microorganisms growing in the culture plate.
In 1929, Alexander Fleming observed that Staphylococcus aureus growth was
inhibited when a mold accidently grew in it.
Later on this accidental drug was known as wonder drug – Penicillin and was
found to be produced by Penicillium notatum.
Streptomycin produced by Streptomyces griseus was the second antibiotic
invented by Dr. Selman Waksman in 1948.
Fig. Dr. Selman Waksman and structure of
Streptomycin
Antibiotics belong to the broader group of antimicrobial compounds
that are used to treat infections caused by microorganisms including
fungi and protozoa.
Antibiotics were originally produced by natural living organisms like
aminoglycosides produced by Streptomyces genus, but some are
semisynthetic like cephalosporins, carbapenems or synthetic like the
sulphonamides, quinolone and oxazolidinones.
Principles of antibiotic therapy
• The antibiotic therapy is based on theory of selective toxicity
that is antibiotic can kill microorganism without causing harm to body of
patient.
• Various antibiotics either inhibit or destroy the metabolic properties
of bacteria.
For example, penicillin inhibits the peptidoglycan in the cell wall of bacter
• For an antibiotic to be effective a fixed dose has to be given to a
patient otherwise it could harm him/her.
• This difference between a dose necessary for treatment of a disease
and the one that may harm a person is large and is called as
therapeutic index.
 Antibiotics may be divided into two broad categories according to their
effect on microorganisms: bactericidal agents, those that kill bacteria and
bacteriostatic agents, those that inhibit bacterial growth.
 Antimicrobial agents are called as broad spectrum when they act against a
wide range of Gram-positive and Gram-negative bacteria like tetracyclin,
erythromycin and cephalisporins.
 They can be narrow spectrum with limited action like penicillin to Gram
positive bacteria. Metronidazole is also a narrow spectrum antibiotic
because of its activity against strict anaerobes and some protozoa.
1.Competition with a natural substance for the active site of the
enzyme, e.g. action of sulphonamides to interfere competitively
with the utilization of PABA or action of PABA with para-
aminosalicylic acid.
2.Combination with an enzyme at a site sufficiently close to the
active site so as to interfere with its enzymatic function, like
vancomycin, ristocetin and bacitracin.
3.Combination with non-enzymatic structural components, like
drugs which inhibit protein synthesis and which act by damaging
cytoplasmic membranes.
The antibiotic chosen for treatment of a disease depends on following factors:
 Location of infection: The site or location of infection is important in choosing
an antibiotic because to treat an infection antibiotic must be in sufficient
concentration at that particular site. For example, the sites with insufficient
supply of blood. Some sites with low pH inhibit certain antibiotics.
 Organism: Specific identification of the organism predicts the natural history of
the infection and allows treatment strategy and choice of drug to be given.
 Pattern of susceptibility: Some organisms may show good susceptibility
towards an antibiotic but other bacteria may not. For example penicillin is
effective for treating infection of Streptococcus pyogenes although Acinetobacter
and Pseudomonas show resistance. Antibiotics should be chosen to cover the
resistance pattern of all the potential pathogens.
 Severity of infection: In general, oral therapy is used when it is well tolerated and
provides an adequate therapeutic effect, the parenteral route being reserved for
patients who have difficulty taking oral medications or when it is desired to
provide prompter or greater antimicrobial activity. In case of severe infections
antibiotics are given by parenteral route.
 History of allergy: If a person has previous allergic history, the antibiotic’s
choice to be selected for treatment is limited.
 Side effects: Some antibiotics may be associated with harmful side effects and
must be given carefully to a patient. For example, in patients who are already
suffering from renal disease, antibiotic like aminoglycoside should e given
carefully.
 Likelihood of unwanted effects: for example, aminoglycosides should be used
with care in patients with pre-existing renal disease.
 The cost of therapy also affects the choice of antibiotic to be used for treatment.
Mechanism of antibiotic action
The antibiotic treatment causes some side effects also. The effects on human body
are:
Gastrointestinal tract - Antibiotic activity can upset the balance of the normal flora
within the gut, e.g. β-lactams drugs. The commensal bacteria like Candida species,
overgrow and may lead to pseudomembrane colitis.
Skin - Skin may be affected with adverse range of manifestations like mild
urticarial to erythematous lesions or Stevens-Johnson syndrome which could be life
threatening. Generally, discontinuation of antibiotic therapy resolve these issues.
Haemopoietic system -Chloremphenicol produces dose dependant suppression of
bone marrow, granulocytopaenia, thrombocytopaenia and sometimes haemolytic
anaemia.
Renal system - Tetracyclines and aminoglycoside antibiotics may be the cause of
renal toxicity and damage to the convoluted tubules. This antibiotic is given under
medical guidance in patients already suffering from renal diseases.
Some commonly used antibiotics
Beta-lactam antibiotics like penicillin
Penicillins work by inhibiting peptidoglycan cross-linkage. Modifications to the
penicillins have extended their antibacterial spectrum and improved absorption.
Penicillins now include:
 natural penicillins e.g. benzylpenicillin and penicillin V
 penicillinase-resistant penicillin e.g. flucloxacillin
 aminopenicillins e.g. ampicillin-like agents
 expanded-spectrum penicillins e.g. piperacillin
 penicillins combined with β-lactamase inhibitors e.g. amoxicillin and clavulanate
or co-amoxiclav.
Penicillins are secreted by the kidney and have a short half-life. They are
distributed in extracellular fluid, but do not cross the blood-brain barrier unless the
meninges are inflamed.
Cephalosporins
Cephalosporins are closely related to penicillins. They are all active
against Gram-positive organisms and later compounds have activity
against Gram-negative bacteria including Pseudomonas.
Monobactams
They have a broad spectrum of activity, including against anaerobes.
Imipenem and meropenem have antipseudomonal effects and must be
given intravenously.
Aminoglycosides
Aminoglycosides act by preventing translation of mRNA into proteins. They are
given parenterally. They are limited to the extracellular fluid and are excreted in the
urine. Aminoglycosides are toxic to the kidney, which necessitates careful
monitoring of serum concentrations.
Glycopeptides
The glycopeptides such as vancomycin and teicoplanin inhibit peptidoglycan cross-
linking in Gram-positive organisms only. Resistance to them is rare but sometimes
glycopeptide-resistant enterococci - GRE and Staphylococcus aureus are found.
Administration of the drug is intravenous or intraperitoneal because they are not
absorbed orally. The exception is the oral use of vancomycin to treat
pseudomembranous colitis.
They are distributed in the extracellular fluid, but do not cross the blood-brain
barrier unless there is meningeal inflammation. Excretion is via the kidney.
Quinolones
Quinolones act by inhibiting bacterial DNA gyrase. The early
quinolones did not attain high tissue levels and were used only for
UTIs. Fluorine modification (fluoroquinolones) has made them
active against Gram-negative pathogens including Chlamydia.
Ciprofloxacin has activity against Pseudomonas spp. Quinolones
are well absorbed orally, are widely distributed and penetrate cell
well.
Macrolides and Oxazolidinones
The macrolides (erythromycin, azithromycin and clarithromycin) and
oxazolidinones e.g. linezolid bind to the 50S ribosome, interfering with
protein synthesis. Linezolid is well absorbed orally and concentrated in
the skin.
They are active against Gram-positive cocci, many anaerobes (but not
Bacteroides), Mycoplasma and Chlamydia. They are absorbed orally,
distributed in the total body water, cross the placenta, are concentrated in
macrophages, polymorphs and the liver and are excreted in the bile.
Erythromycin may cause nausea. The newer macrolides e.g.
azithromycin is well tolerated and is less toxic.
Streptogramins
Pristinamycin is a bactericidal semisynthetic streptogramin
consisting of quinupristin and dalfopristin. It acts by preventing
peptide bond formation, which results in release of incomplete
polypeptide chains from the donor site. It is active against a broad
range of Gram-positive pathogens and some Gram-negatives, such as
Moraxella, Legionella, Neisseria meningitidis and Mycoplasma. It is
used mainly for the treatment of resistant Gram-positive infections
like GRE and glycopeptide-intermediate S. aureus or GISA.
Metronidazole
The main features of metronidazole are that it is;
 active against all anaerobic organisms;
 a receiver of electrons under anaerobic conditions, so forms toxic
metabolites that damage bacterial DNA;
 also active against some species of protozoa, including Giardia, Entamoeba
histolytica and Trichomonas vaginalis;
 absorbed orally and can be administered parenterally;
 widely distributed in the tissues, crossing the blood-brain barrier and
penetrating into abscesses;
 metabolized in the liver and excreted in the urine;
 well tolerated, except that it cannot be taken with alcohol.
Tetracyclines
Tetracyclines act by inhibition of protein synthesis by locking tRNA
to the septal site of mRNA. They are active against many Gram-
positive and some Gram-negative
pathogens, Chlamydia, Mycoplasma, Rickettsia and
Treponemes, Plasmodium and Entamoeba histolytica. Doxycycline
is absorbed orally, has a long half-life and is widely distributed.
Adequate therapeutic levels may be obtained by a once-daily dosage.
The newer tetracyclines such as tigecycline are used to treat
multiresistant Gram-negative infections.
Sulphonamides and trimethoprim
Sulphonamides and trimethoprim act by inhibiting the synthesis of
tetrahydrofolate. They are now rarely used in the treatment of bacterial
infections but have an important role in the management of
Pneumocystis jiroveci and protozoan infections including malaria.
Sulphonamides can be given intravenously and are well absorbed when
given orally. They are widely distributed in the tissues and cross the
blood-brain barrier. They are metabolized in the liver and excreted via
the kidney.
Resistance against drugs
Resistance can develop quickly because:
 bacteria multiply rapidly & mutations arise regularly
 segments of DNA can be transferred by transformation
 genetic information can be transferred rapidly by bacteriophages,
plasmids or other mobile genetic elements.
 Antibiotic’s overuse, misuse and abuse favours the emergence and
survival of resistant organisms. The misuse of antibiotics includes
failure to take the prescribed course of the antibiotics or to take the
course of treatment at incorrect daily intervals.
Avoiding development of drug resistance
Development of drug resistance can be avoided or minimised by:
1.Using correct dosage of the proper antibiotics to overcome an infection
quickly.
2.Using combination of antibiotics.
3.Avoiding indiscriminate use of antibiotics in unnecessary situations.
4.Using a different antibiotic when an organism shows evidence of
becoming resistant.
5.Not to use antibiotics without physician’s prescription.

More Related Content

What's hot

IMMUNITY
IMMUNITYIMMUNITY
4. Laboratory methods for identification of microorganisms (Microbiology)
4. Laboratory methods for identification of microorganisms (Microbiology)4. Laboratory methods for identification of microorganisms (Microbiology)
4. Laboratory methods for identification of microorganisms (Microbiology)
Jay Khaniya
 
Classification of microorganisms lecture 2
Classification of microorganisms lecture 2Classification of microorganisms lecture 2
Classification of microorganisms lecture 2
Ahmad Farid Azizi
 
Structure of immunoglobulins
Structure of immunoglobulinsStructure of immunoglobulins
Structure of immunoglobulins
Steffi Thomas
 
Classification of microrganisms
Classification of microrganismsClassification of microrganisms
Classification of microrganisms
Parthasarathy Ravichandran
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
Aman Ullah
 
Penicillin
PenicillinPenicillin
Penicillin
Shruthi Rammohan
 
Classification of microorganisms
Classification of microorganismsClassification of microorganisms
Classification of microorganisms
NithyaNandapal
 
Antibacterial agents
Antibacterial agentsAntibacterial agents
Antibacterial agents
Minhaz Ahmed
 
Acquired immunity
Acquired immunityAcquired immunity
Acquired immunity
Riyaz Sheriff
 
Types of immunity
Types of immunityTypes of immunity
Types of immunity
Jsjahnabi
 
Antigen antibody reactions
Antigen antibody reactions Antigen antibody reactions
Antigen antibody reactions
Dr. Aamir Ali Khan
 
Ampicillin Production
Ampicillin ProductionAmpicillin Production
Ampicillin Production
Tanyaradzwa Ngara
 
Types of immunity
Types of immunityTypes of immunity
Types of immunity
Dr Sara Sadiq
 
Microbiology unit 1
Microbiology unit 1Microbiology unit 1
Microbiology unit 1
MAULIK CHAUDHARI
 
Introduction to immune system
Introduction to immune systemIntroduction to immune system
Introduction to immune systemShakira Sulehri
 
Immunity
ImmunityImmunity
Immunity
Auricle Nissim
 
Introduction to microbiology
Introduction to microbiologyIntroduction to microbiology
Introduction to microbiology
Snehal Patel
 

What's hot (20)

IMMUNITY
IMMUNITYIMMUNITY
IMMUNITY
 
4. Laboratory methods for identification of microorganisms (Microbiology)
4. Laboratory methods for identification of microorganisms (Microbiology)4. Laboratory methods for identification of microorganisms (Microbiology)
4. Laboratory methods for identification of microorganisms (Microbiology)
 
Classification of microorganisms lecture 2
Classification of microorganisms lecture 2Classification of microorganisms lecture 2
Classification of microorganisms lecture 2
 
Structure of immunoglobulins
Structure of immunoglobulinsStructure of immunoglobulins
Structure of immunoglobulins
 
Hypersensitivity
HypersensitivityHypersensitivity
Hypersensitivity
 
Classification of microrganisms
Classification of microrganismsClassification of microrganisms
Classification of microrganisms
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
 
Chemotherapy (2)
Chemotherapy (2)Chemotherapy (2)
Chemotherapy (2)
 
Penicillin
PenicillinPenicillin
Penicillin
 
Classification of microorganisms
Classification of microorganismsClassification of microorganisms
Classification of microorganisms
 
Antibacterial agents
Antibacterial agentsAntibacterial agents
Antibacterial agents
 
Acquired immunity
Acquired immunityAcquired immunity
Acquired immunity
 
Types of immunity
Types of immunityTypes of immunity
Types of immunity
 
Antigen antibody reactions
Antigen antibody reactions Antigen antibody reactions
Antigen antibody reactions
 
Ampicillin Production
Ampicillin ProductionAmpicillin Production
Ampicillin Production
 
Types of immunity
Types of immunityTypes of immunity
Types of immunity
 
Microbiology unit 1
Microbiology unit 1Microbiology unit 1
Microbiology unit 1
 
Introduction to immune system
Introduction to immune systemIntroduction to immune system
Introduction to immune system
 
Immunity
ImmunityImmunity
Immunity
 
Introduction to microbiology
Introduction to microbiologyIntroduction to microbiology
Introduction to microbiology
 

Similar to Chemotherapy and antibiotics

Antibiotics in dentistry.pptx
Antibiotics in dentistry.pptxAntibiotics in dentistry.pptx
Antibiotics in dentistry.pptx
ssuser71d7b1
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
qalinsame
 
Rational use of antibiotics
Rational use of antibioticsRational use of antibiotics
Rational use of antibiotics
ZeelNaik2
 
Antibiotics used in dentistry
Antibiotics used in dentistryAntibiotics used in dentistry
Antibiotics used in dentistry
Zirgi Rana
 
Microbiology antibiotics & antimicrobial chemotherapy
Microbiology   antibiotics & antimicrobial chemotherapyMicrobiology   antibiotics & antimicrobial chemotherapy
Microbiology antibiotics & antimicrobial chemotherapyMBBS IMS MSU
 
Antimicrobial drug’s types and classification .pdf
Antimicrobial drug’s types and classification .pdfAntimicrobial drug’s types and classification .pdf
Antimicrobial drug’s types and classification .pdf
HesocaHux
 
4b8c antibiotics used in dentistry
4b8c antibiotics used in dentistry4b8c antibiotics used in dentistry
4b8c antibiotics used in dentistry
sani dental group
 
CHEMOTHERAPY
CHEMOTHERAPYCHEMOTHERAPY
CHEMOTHERAPY
PrashantSharma807
 
Anti microbial drugs
Anti microbial drugsAnti microbial drugs
Anti microbial drugs
Dr. vasavi reddy
 
ANTIMICROBIAL CHEMOTHERAPY group 05.pptx
ANTIMICROBIAL CHEMOTHERAPY group 05.pptxANTIMICROBIAL CHEMOTHERAPY group 05.pptx
ANTIMICROBIAL CHEMOTHERAPY group 05.pptx
colmanny
 
Commonly Prescribed Medications in Dentistr.pptx
Commonly Prescribed Medications in Dentistr.pptxCommonly Prescribed Medications in Dentistr.pptx
Commonly Prescribed Medications in Dentistr.pptx
mohamed omar Ismail
 
ANTIBIOTICS
ANTIBIOTICSANTIBIOTICS
antibiotics and periodontics in periodontal treatment.pptx
antibiotics and periodontics in periodontal treatment.pptxantibiotics and periodontics in periodontal treatment.pptx
antibiotics and periodontics in periodontal treatment.pptx
RashmitaNayak25
 
4022977_2.ppt
4022977_2.ppt4022977_2.ppt
4022977_2.ppt
mousaderhem1
 
Anti-infective therapy
Anti-infective therapyAnti-infective therapy
Anti-infective therapy
Omar Hesham
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
Krishna Gandhi
 
Beta lactam antibiotics
Beta lactam antibioticsBeta lactam antibiotics
Beta lactam antibiotics
Eneutron
 
antibiotics.pptx
antibiotics.pptxantibiotics.pptx
antibiotics.pptx
Krishna Gandhi
 
Chemotherapy Dr. Elbadr 2024 whahshhs.ppt
Chemotherapy Dr. Elbadr 2024 whahshhs.pptChemotherapy Dr. Elbadr 2024 whahshhs.ppt
Chemotherapy Dr. Elbadr 2024 whahshhs.ppt
BraaHariz
 
13- Antibiotics.pdf
13- Antibiotics.pdf13- Antibiotics.pdf
13- Antibiotics.pdf
KhushbuTak2
 

Similar to Chemotherapy and antibiotics (20)

Antibiotics in dentistry.pptx
Antibiotics in dentistry.pptxAntibiotics in dentistry.pptx
Antibiotics in dentistry.pptx
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
 
Rational use of antibiotics
Rational use of antibioticsRational use of antibiotics
Rational use of antibiotics
 
Antibiotics used in dentistry
Antibiotics used in dentistryAntibiotics used in dentistry
Antibiotics used in dentistry
 
Microbiology antibiotics & antimicrobial chemotherapy
Microbiology   antibiotics & antimicrobial chemotherapyMicrobiology   antibiotics & antimicrobial chemotherapy
Microbiology antibiotics & antimicrobial chemotherapy
 
Antimicrobial drug’s types and classification .pdf
Antimicrobial drug’s types and classification .pdfAntimicrobial drug’s types and classification .pdf
Antimicrobial drug’s types and classification .pdf
 
4b8c antibiotics used in dentistry
4b8c antibiotics used in dentistry4b8c antibiotics used in dentistry
4b8c antibiotics used in dentistry
 
CHEMOTHERAPY
CHEMOTHERAPYCHEMOTHERAPY
CHEMOTHERAPY
 
Anti microbial drugs
Anti microbial drugsAnti microbial drugs
Anti microbial drugs
 
ANTIMICROBIAL CHEMOTHERAPY group 05.pptx
ANTIMICROBIAL CHEMOTHERAPY group 05.pptxANTIMICROBIAL CHEMOTHERAPY group 05.pptx
ANTIMICROBIAL CHEMOTHERAPY group 05.pptx
 
Commonly Prescribed Medications in Dentistr.pptx
Commonly Prescribed Medications in Dentistr.pptxCommonly Prescribed Medications in Dentistr.pptx
Commonly Prescribed Medications in Dentistr.pptx
 
ANTIBIOTICS
ANTIBIOTICSANTIBIOTICS
ANTIBIOTICS
 
antibiotics and periodontics in periodontal treatment.pptx
antibiotics and periodontics in periodontal treatment.pptxantibiotics and periodontics in periodontal treatment.pptx
antibiotics and periodontics in periodontal treatment.pptx
 
4022977_2.ppt
4022977_2.ppt4022977_2.ppt
4022977_2.ppt
 
Anti-infective therapy
Anti-infective therapyAnti-infective therapy
Anti-infective therapy
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
 
Beta lactam antibiotics
Beta lactam antibioticsBeta lactam antibiotics
Beta lactam antibiotics
 
antibiotics.pptx
antibiotics.pptxantibiotics.pptx
antibiotics.pptx
 
Chemotherapy Dr. Elbadr 2024 whahshhs.ppt
Chemotherapy Dr. Elbadr 2024 whahshhs.pptChemotherapy Dr. Elbadr 2024 whahshhs.ppt
Chemotherapy Dr. Elbadr 2024 whahshhs.ppt
 
13- Antibiotics.pdf
13- Antibiotics.pdf13- Antibiotics.pdf
13- Antibiotics.pdf
 

More from Anju Rana

Magnet status anju
Magnet status anjuMagnet status anju
Magnet status anju
Anju Rana
 
Unbelievable secrets
Unbelievable secretsUnbelievable secrets
Unbelievable secrets
Anju Rana
 
Physical and mental health presentation
Physical and mental health presentationPhysical and mental health presentation
Physical and mental health presentation
Anju Rana
 
General characteristics of viruses
General characteristics of virusesGeneral characteristics of viruses
General characteristics of viruses
Anju Rana
 
Effect of temp. on venom of bungarus caeruleus
Effect of temp. on venom of bungarus caeruleusEffect of temp. on venom of bungarus caeruleus
Effect of temp. on venom of bungarus caeruleus
Anju Rana
 
General characteristics of pathological fungi
General characteristics of pathological fungiGeneral characteristics of pathological fungi
General characteristics of pathological fungi
Anju Rana
 
Bacillus anthracis
Bacillus anthracisBacillus anthracis
Bacillus anthracis
Anju Rana
 
Biomedical waste management ppt
Biomedical waste management pptBiomedical waste management ppt
Biomedical waste management ppt
Anju Rana
 

More from Anju Rana (8)

Magnet status anju
Magnet status anjuMagnet status anju
Magnet status anju
 
Unbelievable secrets
Unbelievable secretsUnbelievable secrets
Unbelievable secrets
 
Physical and mental health presentation
Physical and mental health presentationPhysical and mental health presentation
Physical and mental health presentation
 
General characteristics of viruses
General characteristics of virusesGeneral characteristics of viruses
General characteristics of viruses
 
Effect of temp. on venom of bungarus caeruleus
Effect of temp. on venom of bungarus caeruleusEffect of temp. on venom of bungarus caeruleus
Effect of temp. on venom of bungarus caeruleus
 
General characteristics of pathological fungi
General characteristics of pathological fungiGeneral characteristics of pathological fungi
General characteristics of pathological fungi
 
Bacillus anthracis
Bacillus anthracisBacillus anthracis
Bacillus anthracis
 
Biomedical waste management ppt
Biomedical waste management pptBiomedical waste management ppt
Biomedical waste management ppt
 

Recently uploaded

TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
vaibhavrinwa19
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
EduSkills OECD
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
EverAndrsGuerraGuerr
 
Chapter -12, Antibiotics (One Page Notes).pdf
Chapter -12, Antibiotics (One Page Notes).pdfChapter -12, Antibiotics (One Page Notes).pdf
Chapter -12, Antibiotics (One Page Notes).pdf
Kartik Tiwari
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
Peter Windle
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
S1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptxS1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptx
tarandeep35
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
DhatriParmar
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
Atul Kumar Singh
 
Normal Labour/ Stages of Labour/ Mechanism of Labour
Normal Labour/ Stages of Labour/ Mechanism of LabourNormal Labour/ Stages of Labour/ Mechanism of Labour
Normal Labour/ Stages of Labour/ Mechanism of Labour
Wasim Ak
 
Best Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDABest Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDA
deeptiverma2406
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
Group Presentation 2 Economics.Ariana Buscigliopptx
Group Presentation 2 Economics.Ariana BuscigliopptxGroup Presentation 2 Economics.Ariana Buscigliopptx
Group Presentation 2 Economics.Ariana Buscigliopptx
ArianaBusciglio
 
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBCSTRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
kimdan468
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
SACHIN R KONDAGURI
 

Recently uploaded (20)

TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
 
Chapter -12, Antibiotics (One Page Notes).pdf
Chapter -12, Antibiotics (One Page Notes).pdfChapter -12, Antibiotics (One Page Notes).pdf
Chapter -12, Antibiotics (One Page Notes).pdf
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
 
S1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptxS1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptx
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
 
Normal Labour/ Stages of Labour/ Mechanism of Labour
Normal Labour/ Stages of Labour/ Mechanism of LabourNormal Labour/ Stages of Labour/ Mechanism of Labour
Normal Labour/ Stages of Labour/ Mechanism of Labour
 
Best Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDABest Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDA
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
Group Presentation 2 Economics.Ariana Buscigliopptx
Group Presentation 2 Economics.Ariana BuscigliopptxGroup Presentation 2 Economics.Ariana Buscigliopptx
Group Presentation 2 Economics.Ariana Buscigliopptx
 
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBCSTRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
 

Chemotherapy and antibiotics

  • 2. HISTORY The term was used in the early 1900s by Paul Ehrlich for use of chemicals to treat any disease (chemo+therapy), such as the use of antibiotics (antibacterial chemotherapy). First modern chemotherapeutic agent was arsphenamine, an arsenic compound discovered in 1907 and used to treat syphilis and was later followed by sulfonamides (sulfa drugs) and penicillin. Nowadays the term ‘any treatment of disease with drugs’ is expressed by a word pharmacotherapy.
  • 3. Chemotherapy is the use of chemical substances having property to inhibit the growth of microorganism in treatment of diseases. The chemical compounds that are used to kill or inhibit the growth of microorganisms already established in the tissues of the body are known as chemotherapeutic agents. It may be given to prolong life or to reduce symptoms of a disease. The first use of drugs to treat cancer was reported in the early 20th century, although it was not originally intended for that purpose.
  • 4. Goodman & Gilman used mustard gas as therapy Mustard gas was used as a chemical warfare agent during World War I and was discovered to be a potent suppressor of hematopoiesis (blood production). The accidental discovery that the mustard gas led to slow progression of cancer cells in body encouraged Goodman and Gilman to use it in patients with Hodgkin’s disease in 1943. From here chemotherapy began.
  • 5.
  • 6. The chemotherapeutic agents are non-specific in action and are cytotoxic. One of the side effects of chemotherapy is damage to the normal cells that divide rapidly and are sensitive to the anti-mitotic drugs like cells in the bone marrow, digestive tract and hair follicles. This induces decreased production of blood cells, inflammation of the lining of the digestive tract and hair loss. Chemotherapy damage or stress cells, which may lead to cell death if apoptosis is initiated.
  • 8. Alkylating agents: These are one of the earliest and commonly used drugs. They damage DNA and stops cancer cells to replicate.
  • 9. Fig. Antimetabolites inhibit the DNA synthesis
  • 10. Anthracyclines: These are drugs used for treatment of cancer and thy act by interfering with enzymes that are necessary for replication of DNA but are not cell cycle specific, e.g. doxorubicin, mitimycin-C and bleomycin. These are derived from Streptomyces percetus. Plant alkaloids: These are derived from plants and are found to inhibit cell division or interfere with necessary enzymes needed for cell division. They can affect at any phase of cell division. They produce toxic effects like haematopoesis or neurological toxicities. Examples of plant alkaloides are: vinca alkaloid, vincristine, paclitaxel and docetaxel.
  • 11. Antibiotics Antibiotics were known by their activities long before they were given this specific name that means ‘against life’. Many years ago the Chinese used moldy curd to treat boils and controlled foot infections by wearing sandals with layer of mold. Pasteur and Joubert realised that growth of anthrax bacillus was inhibited by certain other microorganisms growing in the culture plate. In 1929, Alexander Fleming observed that Staphylococcus aureus growth was inhibited when a mold accidently grew in it.
  • 12. Later on this accidental drug was known as wonder drug – Penicillin and was found to be produced by Penicillium notatum. Streptomycin produced by Streptomyces griseus was the second antibiotic invented by Dr. Selman Waksman in 1948. Fig. Dr. Selman Waksman and structure of Streptomycin
  • 13. Antibiotics belong to the broader group of antimicrobial compounds that are used to treat infections caused by microorganisms including fungi and protozoa. Antibiotics were originally produced by natural living organisms like aminoglycosides produced by Streptomyces genus, but some are semisynthetic like cephalosporins, carbapenems or synthetic like the sulphonamides, quinolone and oxazolidinones.
  • 14. Principles of antibiotic therapy • The antibiotic therapy is based on theory of selective toxicity that is antibiotic can kill microorganism without causing harm to body of patient. • Various antibiotics either inhibit or destroy the metabolic properties of bacteria. For example, penicillin inhibits the peptidoglycan in the cell wall of bacter • For an antibiotic to be effective a fixed dose has to be given to a patient otherwise it could harm him/her. • This difference between a dose necessary for treatment of a disease and the one that may harm a person is large and is called as therapeutic index.
  • 15.
  • 16.  Antibiotics may be divided into two broad categories according to their effect on microorganisms: bactericidal agents, those that kill bacteria and bacteriostatic agents, those that inhibit bacterial growth.  Antimicrobial agents are called as broad spectrum when they act against a wide range of Gram-positive and Gram-negative bacteria like tetracyclin, erythromycin and cephalisporins.  They can be narrow spectrum with limited action like penicillin to Gram positive bacteria. Metronidazole is also a narrow spectrum antibiotic because of its activity against strict anaerobes and some protozoa.
  • 17. 1.Competition with a natural substance for the active site of the enzyme, e.g. action of sulphonamides to interfere competitively with the utilization of PABA or action of PABA with para- aminosalicylic acid. 2.Combination with an enzyme at a site sufficiently close to the active site so as to interfere with its enzymatic function, like vancomycin, ristocetin and bacitracin. 3.Combination with non-enzymatic structural components, like drugs which inhibit protein synthesis and which act by damaging cytoplasmic membranes.
  • 18.
  • 19. The antibiotic chosen for treatment of a disease depends on following factors:  Location of infection: The site or location of infection is important in choosing an antibiotic because to treat an infection antibiotic must be in sufficient concentration at that particular site. For example, the sites with insufficient supply of blood. Some sites with low pH inhibit certain antibiotics.  Organism: Specific identification of the organism predicts the natural history of the infection and allows treatment strategy and choice of drug to be given.  Pattern of susceptibility: Some organisms may show good susceptibility towards an antibiotic but other bacteria may not. For example penicillin is effective for treating infection of Streptococcus pyogenes although Acinetobacter and Pseudomonas show resistance. Antibiotics should be chosen to cover the resistance pattern of all the potential pathogens.
  • 20.  Severity of infection: In general, oral therapy is used when it is well tolerated and provides an adequate therapeutic effect, the parenteral route being reserved for patients who have difficulty taking oral medications or when it is desired to provide prompter or greater antimicrobial activity. In case of severe infections antibiotics are given by parenteral route.  History of allergy: If a person has previous allergic history, the antibiotic’s choice to be selected for treatment is limited.  Side effects: Some antibiotics may be associated with harmful side effects and must be given carefully to a patient. For example, in patients who are already suffering from renal disease, antibiotic like aminoglycoside should e given carefully.  Likelihood of unwanted effects: for example, aminoglycosides should be used with care in patients with pre-existing renal disease.  The cost of therapy also affects the choice of antibiotic to be used for treatment.
  • 22.
  • 23. The antibiotic treatment causes some side effects also. The effects on human body are: Gastrointestinal tract - Antibiotic activity can upset the balance of the normal flora within the gut, e.g. β-lactams drugs. The commensal bacteria like Candida species, overgrow and may lead to pseudomembrane colitis. Skin - Skin may be affected with adverse range of manifestations like mild urticarial to erythematous lesions or Stevens-Johnson syndrome which could be life threatening. Generally, discontinuation of antibiotic therapy resolve these issues. Haemopoietic system -Chloremphenicol produces dose dependant suppression of bone marrow, granulocytopaenia, thrombocytopaenia and sometimes haemolytic anaemia. Renal system - Tetracyclines and aminoglycoside antibiotics may be the cause of renal toxicity and damage to the convoluted tubules. This antibiotic is given under medical guidance in patients already suffering from renal diseases.
  • 24. Some commonly used antibiotics
  • 25. Beta-lactam antibiotics like penicillin Penicillins work by inhibiting peptidoglycan cross-linkage. Modifications to the penicillins have extended their antibacterial spectrum and improved absorption. Penicillins now include:  natural penicillins e.g. benzylpenicillin and penicillin V  penicillinase-resistant penicillin e.g. flucloxacillin  aminopenicillins e.g. ampicillin-like agents  expanded-spectrum penicillins e.g. piperacillin  penicillins combined with β-lactamase inhibitors e.g. amoxicillin and clavulanate or co-amoxiclav. Penicillins are secreted by the kidney and have a short half-life. They are distributed in extracellular fluid, but do not cross the blood-brain barrier unless the meninges are inflamed.
  • 26. Cephalosporins Cephalosporins are closely related to penicillins. They are all active against Gram-positive organisms and later compounds have activity against Gram-negative bacteria including Pseudomonas. Monobactams They have a broad spectrum of activity, including against anaerobes. Imipenem and meropenem have antipseudomonal effects and must be given intravenously.
  • 27. Aminoglycosides Aminoglycosides act by preventing translation of mRNA into proteins. They are given parenterally. They are limited to the extracellular fluid and are excreted in the urine. Aminoglycosides are toxic to the kidney, which necessitates careful monitoring of serum concentrations. Glycopeptides The glycopeptides such as vancomycin and teicoplanin inhibit peptidoglycan cross- linking in Gram-positive organisms only. Resistance to them is rare but sometimes glycopeptide-resistant enterococci - GRE and Staphylococcus aureus are found. Administration of the drug is intravenous or intraperitoneal because they are not absorbed orally. The exception is the oral use of vancomycin to treat pseudomembranous colitis. They are distributed in the extracellular fluid, but do not cross the blood-brain barrier unless there is meningeal inflammation. Excretion is via the kidney.
  • 28. Quinolones Quinolones act by inhibiting bacterial DNA gyrase. The early quinolones did not attain high tissue levels and were used only for UTIs. Fluorine modification (fluoroquinolones) has made them active against Gram-negative pathogens including Chlamydia. Ciprofloxacin has activity against Pseudomonas spp. Quinolones are well absorbed orally, are widely distributed and penetrate cell well.
  • 29. Macrolides and Oxazolidinones The macrolides (erythromycin, azithromycin and clarithromycin) and oxazolidinones e.g. linezolid bind to the 50S ribosome, interfering with protein synthesis. Linezolid is well absorbed orally and concentrated in the skin. They are active against Gram-positive cocci, many anaerobes (but not Bacteroides), Mycoplasma and Chlamydia. They are absorbed orally, distributed in the total body water, cross the placenta, are concentrated in macrophages, polymorphs and the liver and are excreted in the bile. Erythromycin may cause nausea. The newer macrolides e.g. azithromycin is well tolerated and is less toxic.
  • 30. Streptogramins Pristinamycin is a bactericidal semisynthetic streptogramin consisting of quinupristin and dalfopristin. It acts by preventing peptide bond formation, which results in release of incomplete polypeptide chains from the donor site. It is active against a broad range of Gram-positive pathogens and some Gram-negatives, such as Moraxella, Legionella, Neisseria meningitidis and Mycoplasma. It is used mainly for the treatment of resistant Gram-positive infections like GRE and glycopeptide-intermediate S. aureus or GISA.
  • 31. Metronidazole The main features of metronidazole are that it is;  active against all anaerobic organisms;  a receiver of electrons under anaerobic conditions, so forms toxic metabolites that damage bacterial DNA;  also active against some species of protozoa, including Giardia, Entamoeba histolytica and Trichomonas vaginalis;  absorbed orally and can be administered parenterally;  widely distributed in the tissues, crossing the blood-brain barrier and penetrating into abscesses;  metabolized in the liver and excreted in the urine;  well tolerated, except that it cannot be taken with alcohol.
  • 32. Tetracyclines Tetracyclines act by inhibition of protein synthesis by locking tRNA to the septal site of mRNA. They are active against many Gram- positive and some Gram-negative pathogens, Chlamydia, Mycoplasma, Rickettsia and Treponemes, Plasmodium and Entamoeba histolytica. Doxycycline is absorbed orally, has a long half-life and is widely distributed. Adequate therapeutic levels may be obtained by a once-daily dosage. The newer tetracyclines such as tigecycline are used to treat multiresistant Gram-negative infections.
  • 33. Sulphonamides and trimethoprim Sulphonamides and trimethoprim act by inhibiting the synthesis of tetrahydrofolate. They are now rarely used in the treatment of bacterial infections but have an important role in the management of Pneumocystis jiroveci and protozoan infections including malaria. Sulphonamides can be given intravenously and are well absorbed when given orally. They are widely distributed in the tissues and cross the blood-brain barrier. They are metabolized in the liver and excreted via the kidney.
  • 35. Resistance can develop quickly because:  bacteria multiply rapidly & mutations arise regularly  segments of DNA can be transferred by transformation  genetic information can be transferred rapidly by bacteriophages, plasmids or other mobile genetic elements.  Antibiotic’s overuse, misuse and abuse favours the emergence and survival of resistant organisms. The misuse of antibiotics includes failure to take the prescribed course of the antibiotics or to take the course of treatment at incorrect daily intervals.
  • 36. Avoiding development of drug resistance Development of drug resistance can be avoided or minimised by: 1.Using correct dosage of the proper antibiotics to overcome an infection quickly. 2.Using combination of antibiotics. 3.Avoiding indiscriminate use of antibiotics in unnecessary situations. 4.Using a different antibiotic when an organism shows evidence of becoming resistant. 5.Not to use antibiotics without physician’s prescription.